Chronic Kidney Disease-Mineral and Bone Disorder
"Chronic Kidney Disease-Mineral and Bone Disorder" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
| Descriptor ID |
D012080
|
| MeSH Number(s) |
C05.116.198.816.750 C12.777.419.795 C13.351.968.419.795 C18.452.104.816.750 C18.452.174.845.750 C18.654.521.500.133.770.734.750 C19.642.355.480.500
|
| Concept/Terms |
Renal Osteodystrophy- Renal Osteodystrophy
- Osteodystrophies, Renal
- Renal Osteodystrophies
- Osteodystrophy, Renal
|
Below are MeSH descriptors whose meaning is more general than "Chronic Kidney Disease-Mineral and Bone Disorder".
Below are MeSH descriptors whose meaning is more specific than "Chronic Kidney Disease-Mineral and Bone Disorder".
This graph shows the total number of publications written about "Chronic Kidney Disease-Mineral and Bone Disorder" by people in this website by year, and whether "Chronic Kidney Disease-Mineral and Bone Disorder" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chronic Kidney Disease-Mineral and Bone Disorder" by people in Profiles.
-
Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism. Am J Nephrol. 2022; 53(2-3):157-168.
-
Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis. Pediatr Nephrol. 2019 01; 34(1):107-115.
-
Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Clin J Am Soc Nephrol. 2017 Jul 07; 12(7):1118-1127.
-
Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients. Am J Nephrol. 2016; 43(2):85-96.
-
Target levels for serum phosphorus and parathyroid hormone. Semin Dial. 2011 Jan-Feb; 24(1):29-33.
-
Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Am J Kidney Dis. 2010 Nov; 56(5):842-51.
-
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010 Aug; (117):S10-21.
-
Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients. Hemodial Int. 2010 Apr; 14(2):182-92.
-
Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease. Nephrology (Carlton). 2009 Jun; 14(4):408-15.
-
Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol. 2008 Nov; 19(11):2193-203.